Email: s.nekolla AT lrz.tu-muenchen.de
Dr. Stephan G. Nekolla is the Head of Multimodal Cardiac Imaging at Klinikum rechts der Isar of the Technische Universit‰t M¸nchen
(Germany), in whose nuclear medicine division he has been working since 1993 (Director: Markus Schwaiger).
His research fields are acquisition and analysis of PET, SPECT, MRI and CT cardiac studies, workflow considerations and
quantification methods both in clinical and pre-clinical studies. Dr. Nekolla is author and co-author of over 100 peer
reviewed publications with accumulated impact factors of over 600 and creator of the analysis tool "MunichHeart" which
is used in several international cardiac research centers. After studying physics at the Univ. W¸rzburg, Germany (1983-1989)
and his diploma thesis at the Institute of Biotechnology on "Fourieranalysis Based Signal analysis with Membranproteins",
he received his Ph.D. at the Institute of Physics, Univ. W¸rzburg, Axel Haase, Department of Biophysics on
"Postprocessing in Quantitative Nuclear Magnetic Resonance" (1989-1993).
Most recent, relevant papers and review articles:
1. Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects. Rischpler C, Nekolla SG, Dregely I, Schwaiger M. J Nucl Med. 2013
2. Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress-induced transient midventricular ballooning syndrome: a variant of takotsubo cardiomyopathy. Ibrahim T, Nekolla SG, Langwieser N, Rischpler C, Groha P, Laugwitz KL, Schwaiger M. Circulation. 2012 Nov 20;126(21):e324-6
3. Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology. Martinez-Möller A, Eiber M, Nekolla SG, Souvatzoglou M, Drzezga A, Ziegler S, Rummeny EJ, Schwaiger M, Beer AJ. J Nucl Med. 2012 Sep;53(9):1415-26. Epub 2012 Aug 9
4. First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses. Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ, Schwaiger M. J Nucl Med. 2012 Jun;53(6):845-55. Epub 2012 Apr 25.
5. Molecular Imaging of Early αvβ3 Integrin Expression Predicts Long-Term Left-Ventricle Remodeling After Myocardial Infarction in Rats. Sherif HM, Saraste A, Nekolla SG, Weidl E, Reder S, Tapfer A, Rudelius M, Higuchi T, Botnar RM, Wester HJ, Schwaiger M. J Nucl Med. 2012 Feb;53(2):318-23
6. Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner. Delso G, Fürst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, Schwaiger M, Ziegler SI. J Nucl Med. 2011 Nov 14. [Epub ahead of print]
7. Simpliﬁed Quantiﬁcation of Myocardial Flow Reserve with 18 F-Flurpiridaz: Validation with Microspheres in a Pig Model Sherif HM, Nekolla SG, Saraste A, Reder S, Yu M, Robinson S, Schwaiger M. J Nucl Med 2011; 52:617-624
8. Novel F-18-Labeled PET Myocardial Perfusion Tracers: Bench to Bedside. Nekolla SG, Saraste A. Curr Cardiol Rep. 2011;13(2):145-50
9. PET/CT challenge for the non-invasive diagnosis of coronary artery disease. Schwaiger M, Ziegler SI, Nekolla SG. Eur J Radiol. 2010 Mar;73(3):494-503
10. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schömig A, Schwaiger M. Radiology. 2010 Jan;254(1):88-97
[Research] [Private] [Gallery] [MunichHeart] [Resources] [MRI|NM]
© Stephan Nekolla 2009